Fri, 09/14/2018 - 11:00
I'm so sorry your mother-in-law is dealing with lung cancer with everything else going on. It's good to hear she was given a blood biopsy it's very exciting to know people won't always need a tissue biopsy for mutation testing. Osimertinib, brand name tagrisso and in some countries tagrix has been used in people with a subset of nsclc with very good results. The side effect profile is about as good as it gets for anti cancer drugs with the major side effects being rash and diarrhea, most of which can be managed. And since it is a pill you don't need to go in to the office for treatment. Osimertinib has recently been approved by FDA as first line treatment. This makes osimertinib an good choice for those who have comorbidities.
I'm sorry that Grace is not easy to navigate at the moment. We just moved to a new site and still have work to be done. It should continue to get better.
Here's a link to a post by Dr. Ramalingam on the subject, https://www.onclive.com/web-exclusives/fda-approves-frontline-osimertin…
Best of luck,
Fri, 09/14/2018 - 11:02
The link I've posted doesn't work so you'll need to copy and search or paste. A work in progress.